Form D · Biotechnology
Continuity Biosciences, LLC
Bradenton, FL · CIK 0002029079
Offering snapshot reported Aug 19, 2025 · SEC filing
- Reported sold
- $8.42M Offering amount: $12M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2025 | Initial | $8,424,490 | No comparison | 13 | SEC filing |
| Jun 4, 2025 | Initial | $1,000,000 | No comparison | 13 | SEC filing |
| Jul 2, 2024 | Initial | $2,450,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555132
Source: Form D, filed Aug 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph De Simone | Director |
| Michael L. Fowler | Director |
| Monica P. Reed | Director |
| Josephine Torrente | Director |
| Ramakrishna Venugopalan | Director, Executive |
| Allen R. Weiss | Director |
| Robert Whitehead | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8476 Lindrick Lane
Bradenton, FL, 34202
Bradenton, FL, 34202